Full-Time

Senior Director, Global Environmental Health and Safety

Updated on 8/1/2026

Deadline 4/15/27
Waters Corporation

Waters Corporation

10,001+ employees

Analytical instruments, software, and services provider

No salary listed

Milford, MA, USA

In Person

Travel required 30% of the time.

Category
Lab & Research (1)
Required Skills
OSHA

Get referred to Waters Corporation

See people who can refer or advise you

Requirements
  • A bachelor's degree is required.
  • At least 15 years of progressive environmental, health, and safety leadership experience in regulated industries such as life sciences, pharmaceuticals, biotechnology, or chemicals.
  • Proven experience managing global environmental, health, and safety programs and teams.
  • Demonstrated success in regulatory compliance, safety culture development, and risk mitigation.
  • Strong understanding of environmental, health, and safety regulations across multiple regions.
  • Knowledge of environmental, health, and safety management systems, audit protocols, risk assessments, and incident investigation methodologies.
  • A track record of leading organizational change, implementing global standards, and improving operational performance.
  • Ability to define and execute a global environmental, health, and safety strategy aligned with business objectives.
  • Experience driving organizational transformation and standardization across regions.
  • Strong decision-making based on data, risk assessment, and cost-benefit analysis.
  • Ability to present complex technical and financial information to senior leadership and external stakeholders.
  • Ability to work with international teams across different time zones.
Responsibilities
  • Develop and implement a global environmental, health, and safety strategy aligned with corporate objectives, regulatory requirements, and industry best practices.
  • Lead ISO 14001 and ISO 45001 management systems, ensuring global sites maintain certification and continuous improvement.
  • Establish governance frameworks, global standards, and environmental, health, and safety policies to ensure consistency and accountability across all regions.
  • Promote a behavior-based safety culture across the enterprise by embedding safe behaviors into daily operations.
  • Ensure compliance with global environmental, occupational health, and safety regulations, including Occupational Safety and Health Administration requirements and equivalents worldwide, Environmental Protection Agency requirements and international environmental regulators, and local and regional regulatory authorities.
  • Lead preparation for regulatory inspections, audits, and certifications.
  • Oversee Process Safety Management programs for high-hazard manufacturing operations, ensuring compliance with regulatory standards and company policies.
  • Identify, mitigate, and monitor environmental, health, and safety risks, including chemical, biological, physical, and environmental hazards.
  • Partner with regional operations, manufacturing, laboratories, and facilities teams to drive compliance and operational excellence.
  • Oversee incident investigations, root cause analysis, and corrective action implementation across all sites.
  • Lead programs for industrial hygiene, environmental monitoring, occupational health, and sustainability initiatives.
  • Develop and implement global environmental, health, and safety training programs.
  • Promote a culture of safety, compliance, and continuous improvement across all levels of the organization.
  • Mentor and develop regional environmental, health, and safety leaders to foster consistency in execution and leadership capability.
  • Lead a global organization of regional environmental, health, and safety leaders in high-complexity and regulated environments.
  • Establish and track environmental, health, and safety performance metrics, including incident rates, audit findings, near misses, and corrective actions.
  • Drive continuous improvement programs to enhance safety, environmental stewardship, and regulatory compliance.

Waters Corporation provides analytical system solutions, software, and services for scientists across biopharma, clinical research, forensics, life science research, food and beverage, and environmental sectors. Its products include high-performance analytical instruments like the BioAccord System, paired with software and ongoing support to enable precise, reproducible results. The company operates by selling instruments and software and offering maintenance and services to enhance user experience and reliability. Compared to competitors, Waters offers an integrated package of hardware, software, and service across multiple markets, focused on delivering accurate analyses and end-to-end workflow solutions rather than just standalone devices. Its goal is to unlock the potential of science by solving problems that affect human health and well-being.

Company Size

10,001+

Company Stage

IPO

Headquarters

Milford, Connecticut

Founded

1958

Get referred to Waters Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Biopharma spending supports instrument refreshes and consumables pull-through.
  • Clinical diagnostics applications expand with earlier disease detection demand.
  • Food, water, and environmental testing create diversified compliance-driven growth.

What critics are saying

  • Thermo Fisher, Danaher, and Agilent pressure pricing and platform share.
  • Chinese vendors undercut Waters in cost-sensitive public labs and CROs.
  • Biopharma capital spending delays weaken system sales and consumables demand.

What makes Waters Corporation unique

  • Waters dominates regulated chromatography and mass spectrometry workflows.
  • Its portfolio combines instruments, informatics, consumables, and services.
  • Biopharma generated 58% of 2024 sales, anchoring recurring demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

16%

1 year growth

16%

2 year growth

14%
PR Newswire
Apr 14th, 2026
Waters launches omniDAWN MALS detector for UHPLC, enabling 4x faster analysis of large molecules

Waters Corporation has launched the omniDAWN Multi-Angle Light Scattering Photometer, the first extended-range MALS detector designed for ultra high performance liquid chromatography workflows. The device features 18 detection angles and delivers chromatographic run times up to four times faster than conventional methods. The photometer extends UPLC-compatible sizing tenfold, from approximately 50 to 500 nanometres in radius, enabling characterisation of complex molecules including protein aggregates, viral vectors and lipid nanoparticles. It achieves a 10-fold improvement in absolute molar mass measurements whilst reducing sample consumption by 30–50% and solvent use by roughly 40%. The device integrates with Waters UPLC systems and is powered by ASTRA software, supporting analysis across drug discovery, development and quality control. The omniDAWN photometer will be available globally in summer 2026.

PR Newswire
Apr 8th, 2026
Waters gains FDA clearance for at-home cervical cancer screening kit with HPV assay

Waters Corporation has received FDA clearance for the Onclarity HPV Self-Collection Kit and approval for the BD Onclarity HPV Assay with extended genotyping for at-home use. The kit enables cervical cancer screening from home, addressing barriers that prevent many individuals from routine testing. Approximately 60% of cervical cancer cases occur in unscreened or under-screened individuals. The BD Onclarity HPV Assay is the only FDA-approved test identifying six individual HPV genotypes and three pooled groups, making it the most comprehensive screening tool available in the US. The kit will be available by prescription in coming months and is covered by private insurance, Medicaid and Medicare. Waters is establishing partnerships for broader nationwide access, with patients able to collect samples at home and mail them to laboratories for processing.

Paul Hastings LLP
Mar 23rd, 2026
Waters Corporation subsidiary raises $3.5B through senior notes offering

Paul Hastings advised underwriters including Barclays Capital, Citigroup Global Markets and J.P. Morgan Securities in a $3.5 billion senior notes offering by Augusta SpinCo Corporation, a Waters Corporation subsidiary. The SEC-registered offering comprises five tranches of senior notes maturing between 2027 and 2036, with interest rates ranging from 4.321% to 5.245%. The notes are guaranteed by Waters and certain subsidiaries. Partner Jeff Ramsay led the Paul Hastings team, which included partners Morgan Bale, Ismael Duran and Daniel Nicholas, along with several associates.

Yahoo Finance
Mar 19th, 2026
Waters Corporation stock down 22.8% year-on-year, underperforming Dow's 11.2% rise

Waters Corporation (WAT), a leading scientific instruments manufacturer, is underperforming the Dow Jones Industrial Average significantly. The stock trades 28.8% below its 52-week high of $414.15 and has declined 22.3% year-to-date, compared to the Dow's 3.8% decline. The Milford, Massachusetts-based company, with a market cap of $28.9 billion, specialises in analytical technologies including liquid chromatography and mass spectrometry for pharmaceutical, life sciences and industrial applications. Despite reporting solid fourth-quarter results with revenue of $932 million, up 7% year-over-year, and adjusted earnings per share rising 10% to $4.53, investor sentiment has soured. Cautious first-quarter guidance and concerns over its acquisition of Becton Dickinson's biosciences unit, which is underperforming expectations, have weighed on the stock.

Yahoo Finance
Mar 17th, 2026
Waters Corporation Q4 results mixed as research tools sector faces 20.9% share price decline

Waters Corporation reported Q4 revenues of $932.4 million, down 45.4% year on year, meeting analysts' expectations. The analytical instruments manufacturer delivered mixed results, with next quarter's revenue guidance exceeding expectations but earnings per share guidance falling short. The research tools and consumables sector reported a satisfactory Q4 overall, with the 10 tracked stocks beating revenue consensus estimates by 1.2%. However, share prices have struggled, declining 20.9% on average since latest earnings results. Founded in 1958, Waters develops analytical instruments, software and consumables for liquid chromatography, mass spectrometry and thermal analysis. CEO Udit Batra highlighted the company achieved high single-digit revenue growth and double-digit adjusted EPS growth in 2025, with momentum expected to continue into 2026.